​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.

​​

Section1

​Announcements

​​
  • UPCOMING MEETING: The Prescription Drug Affordability Board Meeting that was canceled on January 26, 2026 has been rescheduled to February 23, 2026 at 9:00 AM ET. Meeting information can be found here.​ 

  • UPCOMING MEETING: ​The Prescription Drug Affordability Board Stakeholder Council will have a regularly scheduled meeting on February 23, 2026 at 2:00 PM ET. Meeting information can be found here.​​​​​​​

  • Written Comment Request: 
    In accordance with COMAR 14.01.05.06D(4), staff has posted its recommendation for a proposed UPL amount and methodology for Jardiance and Farxiga and is hereby requesting public written comment. Comments may be submitted in accordance with COMAR 14.01.01.05B(4) by close of business, Wednesday, March 4, 2026.  More information can be found here​. ​​
  • Join the PDAB Mailing List here​.​


Section2

Get Inv​olved​​​

​​​​

Section3

Section5